These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823 [TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic Ape1 expression elevated by p53 aberration may predict survival and relapse in resected non-small cell lung cancer. Wu HH; Chu YC; Wang L; Tsai LH; Lee MC; Chen CY; Shieh SH; Cheng YW; Lee H Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S336-47. PubMed ID: 22688662 [TBL] [Abstract][Full Text] [Related]
5. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas. Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788 [TBL] [Abstract][Full Text] [Related]
6. MnSOD overexpression confers cisplatin resistance in lung adenocarcinoma via the NF-κB/Snail/Bcl-2 pathway. Chen PM; Cheng YW; Wu TC; Chen CY; Lee H Free Radic Biol Med; 2015 Feb; 79():127-37. PubMed ID: 25499851 [TBL] [Abstract][Full Text] [Related]
7. Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters. Saidj D; Cros MP; Hernandez-Vargas H; Guarino F; Sylla BS; Tommasino M; Accardi R J Virol; 2013 Nov; 87(22):12139-50. PubMed ID: 24006445 [TBL] [Abstract][Full Text] [Related]
8. LATS2 inhibits the activity of NF-κ B signaling by disrupting the interaction between TAK1 and IKKβ. Yao F; Zhou W; Zhong C; Fang W Tumour Biol; 2015 Sep; 36(10):7873-9. PubMed ID: 25946971 [TBL] [Abstract][Full Text] [Related]
9. KINK-1, a novel small-molecule inhibitor of IKKbeta, and the susceptibility of melanoma cells to antitumoral treatment. Schön M; Wienrich BG; Kneitz S; Sennefelder H; Amschler K; Vöhringer V; Weber O; Stiewe T; Ziegelbauer K; Schön MP J Natl Cancer Inst; 2008 Jun; 100(12):862-75. PubMed ID: 18544741 [TBL] [Abstract][Full Text] [Related]
10. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription. Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312 [TBL] [Abstract][Full Text] [Related]
11. Nkx2.1 transcription factor in lung cells and a transforming growth factor-beta1 heterozygous mouse model of lung carcinogenesis. Kang Y; Hebron H; Ozbun L; Mariano J; Minoo P; Jakowlew SB Mol Carcinog; 2004 Aug; 40(4):212-31. PubMed ID: 15264213 [TBL] [Abstract][Full Text] [Related]
12. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer. Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137 [TBL] [Abstract][Full Text] [Related]
13. Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation. Zheng Z; Li H; Zhang Z; Meng J; Mao D; Bai B; Lu B; Mao P; Hu Q; Wang H J Immunol; 2011 Sep; 187(5):2202-12. PubMed ID: 21810613 [TBL] [Abstract][Full Text] [Related]
14. Prolyl hydroxylase-3 is down-regulated in colorectal cancer cells and inhibits IKKbeta independent of hydroxylase activity. Xue J; Li X; Jiao S; Wei Y; Wu G; Fang J Gastroenterology; 2010 Feb; 138(2):606-15. PubMed ID: 19786027 [TBL] [Abstract][Full Text] [Related]
15. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β. Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840 [TBL] [Abstract][Full Text] [Related]
16. Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer. Hernandez L; Hsu SC; Davidson B; Birrer MJ; Kohn EC; Annunziata CM Cancer Res; 2010 May; 70(10):4005-14. PubMed ID: 20424119 [TBL] [Abstract][Full Text] [Related]
17. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues]. Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209 [TBL] [Abstract][Full Text] [Related]
18. NF-kappaB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis. Kang MJ; Ryu BK; Lee MG; Han J; Lee JH; Ha TK; Byun DS; Chae KS; Lee BH; Chun HS; Lee KY; Kim HJ; Chi SG Gastroenterology; 2008 Dec; 135(6):2030-42, 2042.e1-3. PubMed ID: 18824170 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer. Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716 [TBL] [Abstract][Full Text] [Related]
20. Sp1 upregulates survivin expression in adenocarcinoma of lung cell line A549. Chen Y; Wang X; Li W; Zhang H; Zhao C; Li Y; Wang Z; Chen C Anat Rec (Hoboken); 2011 May; 294(5):774-80. PubMed ID: 21433308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]